

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | porphyrin-containing compound metabolic process (GO:0006778) | 9.48695221 |
| 2 | erythrocyte maturation (GO:0043249) | 9.39641576 |
| 3 | heme metabolic process (GO:0042168) | 8.86574616 |
| 4 | hemoglobin metabolic process (GO:0020027) | 8.63183151 |
| 5 | response to methylmercury (GO:0051597) | 6.95250493 |
| 6 | erythrocyte development (GO:0048821) | 6.90138802 |
| 7 | negative regulation of cell killing (GO:0031342) | 6.23087109 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.23087109 |
| 9 | tetrapyrrole metabolic process (GO:0033013) | 6.07761600 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.97417646 |
| 11 | response to lead ion (GO:0010288) | 5.70419346 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.70049637 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 5.70049637 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 5.70049637 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 5.70049637 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.70049637 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.70049637 |
| 18 | response to insecticide (GO:0017085) | 5.40971189 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.35711762 |
| 20 | erythrocyte differentiation (GO:0030218) | 5.20267862 |
| 21 | microglial cell activation (GO:0001774) | 5.10409055 |
| 22 | myeloid cell development (GO:0061515) | 4.95989553 |
| 23 | pigment biosynthetic process (GO:0046148) | 4.94603381 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 4.94362586 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.77856129 |
| 26 | oxygen transport (GO:0015671) | 4.69538897 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 4.68043944 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 4.66663885 |
| 29 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.62557013 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.53865336 |
| 31 | detection of other organism (GO:0098543) | 4.49717607 |
| 32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.49097783 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.47963694 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.44379743 |
| 35 | regulation of response to osmotic stress (GO:0047484) | 4.43508723 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.41848712 |
| 37 | response to arsenic-containing substance (GO:0046685) | 4.36791340 |
| 38 | cellular extravasation (GO:0045123) | 4.35390345 |
| 39 | detection of external biotic stimulus (GO:0098581) | 4.33625932 |
| 40 | neutrophil mediated immunity (GO:0002446) | 4.26272616 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.26175793 |
| 42 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.20097243 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.20056145 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17757530 |
| 45 | plasma lipoprotein particle assembly (GO:0034377) | 4.14537082 |
| 46 | pigment metabolic process (GO:0042440) | 4.12486792 |
| 47 | detection of bacterium (GO:0016045) | 4.10393913 |
| 48 | macrophage activation (GO:0042116) | 4.06903071 |
| 49 | response to interleukin-15 (GO:0070672) | 4.01831738 |
| 50 | iron ion import (GO:0097286) | 3.92310093 |
| 51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.89864506 |
| 52 | response to host immune response (GO:0052572) | 3.89864506 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 3.88163160 |
| 54 | leukocyte aggregation (GO:0070486) | 3.85822497 |
| 55 | neutrophil activation (GO:0042119) | 3.85600943 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85303358 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.83741592 |
| 58 | response to peptidoglycan (GO:0032494) | 3.82991419 |
| 59 | negative regulation of viral entry into host cell (GO:0046597) | 3.81005608 |
| 60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.80791112 |
| 61 | myeloid leukocyte mediated immunity (GO:0002444) | 3.76874353 |
| 62 | bicarbonate transport (GO:0015701) | 3.75724880 |
| 63 | embryonic hemopoiesis (GO:0035162) | 3.74042383 |
| 64 | protein-lipid complex assembly (GO:0065005) | 3.73252647 |
| 65 | regulation of DNA endoreduplication (GO:0032875) | 3.73195930 |
| 66 | detection of biotic stimulus (GO:0009595) | 3.72631618 |
| 67 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.72141417 |
| 68 | definitive hemopoiesis (GO:0060216) | 3.68760000 |
| 69 | mitotic sister chromatid segregation (GO:0000070) | 3.64320759 |
| 70 | respiratory burst (GO:0045730) | 3.63099479 |
| 71 | positive regulation of granulocyte differentiation (GO:0030854) | 3.62713355 |
| 72 | response to host (GO:0075136) | 3.59780548 |
| 73 | response to host defenses (GO:0052200) | 3.59780548 |
| 74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.59780548 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57571119 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 3.57047716 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.56076071 |
| 78 | sister chromatid segregation (GO:0000819) | 3.55355079 |
| 79 | one-carbon compound transport (GO:0019755) | 3.54811286 |
| 80 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.53001293 |
| 81 | B cell receptor signaling pathway (GO:0050853) | 3.49373754 |
| 82 | megakaryocyte development (GO:0035855) | 3.48055563 |
| 83 | platelet formation (GO:0030220) | 3.47862002 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 3.46435580 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.45846406 |
| 86 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.45837553 |
| 87 | granulocyte activation (GO:0036230) | 3.44378063 |
| 88 | positive thymic T cell selection (GO:0045059) | 3.42642172 |
| 89 | negative T cell selection (GO:0043383) | 3.37340304 |
| 90 | negative thymic T cell selection (GO:0045060) | 3.35872845 |
| 91 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.30900716 |
| 92 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.30472529 |
| 93 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.30255211 |
| 94 | mitotic chromosome condensation (GO:0007076) | 3.29800948 |
| 95 | actin filament capping (GO:0051693) | 3.29039499 |
| 96 | regulation of B cell differentiation (GO:0045577) | 3.28511366 |
| 97 | positive T cell selection (GO:0043368) | 3.27123461 |
| 98 | regulation of mast cell degranulation (GO:0043304) | 3.21091524 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 3.19705031 |
| 100 | regulation of necroptotic process (GO:0060544) | 3.18664181 |
| 101 | leukocyte degranulation (GO:0043299) | 3.17770740 |
| 102 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.11539959 |
| 103 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.09397027 |
| 104 | regulation of erythrocyte differentiation (GO:0045646) | 3.06455571 |
| 105 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.04957355 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.04957355 |
| 107 | activated T cell proliferation (GO:0050798) | 3.04935603 |
| 108 | protein localization to chromosome, centromeric region (GO:0071459) | 3.03769077 |
| 109 | response to type I interferon (GO:0034340) | 3.03211077 |
| 110 | type I interferon signaling pathway (GO:0060337) | 3.01838437 |
| 111 | cellular response to type I interferon (GO:0071357) | 3.01838437 |
| 112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00629658 |
| 113 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.98248751 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96432032 |
| 115 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94757330 |
| 116 | hepatocyte apoptotic process (GO:0097284) | 2.94716432 |
| 117 | chromatin assembly (GO:0031497) | 2.94520232 |
| 118 | regulation of platelet aggregation (GO:0090330) | 2.93954128 |
| 119 | regulation of viral entry into host cell (GO:0046596) | 2.93853861 |
| 120 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.92847397 |
| 121 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.92847397 |
| 122 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.92847397 |
| 123 | granulocyte differentiation (GO:0030851) | 2.91277243 |
| 124 | immunoglobulin mediated immune response (GO:0016064) | 2.90982893 |
| 125 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.90570377 |
| 126 | positive regulation of interferon-alpha production (GO:0032727) | 2.90222170 |
| 127 | regulation of mast cell activation (GO:0033003) | 2.89999983 |
| 128 | positive regulation of mast cell activation (GO:0033005) | 2.89905588 |
| 129 | negative regulation of adaptive immune response (GO:0002820) | 2.87628941 |
| 130 | protein localization to kinetochore (GO:0034501) | 2.86934278 |
| 131 | dendritic cell migration (GO:0036336) | 2.86046165 |
| 132 | gas transport (GO:0015669) | 2.85700130 |
| 133 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.84553283 |
| 134 | cofactor biosynthetic process (GO:0051188) | 2.84317183 |
| 135 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84178219 |
| 136 | negative regulation of B cell mediated immunity (GO:0002713) | 2.84112985 |
| 137 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.84112985 |
| 138 | heme transport (GO:0015886) | 2.83880167 |
| 139 | positive regulation of chromosome segregation (GO:0051984) | 2.73861216 |
| 140 | nucleosome assembly (GO:0006334) | 2.63943896 |
| 141 | negative regulation of actin filament depolymerization (GO:0030835) | 2.59105433 |
| 142 | DNA unwinding involved in DNA replication (GO:0006268) | 2.58645878 |
| 143 | plasma lipoprotein particle organization (GO:0071827) | 2.57270503 |
| 144 | cellular response to dexamethasone stimulus (GO:0071549) | 2.54241005 |
| 145 | antibacterial humoral response (GO:0019731) | 2.50565743 |
| 146 | kinetochore organization (GO:0051383) | 2.49297090 |
| 147 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.49087411 |
| 148 | innate immune response in mucosa (GO:0002227) | 2.48294016 |
| 149 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.47432476 |
| 150 | response to dexamethasone (GO:0071548) | 2.47221551 |
| 151 | protein-lipid complex subunit organization (GO:0071825) | 2.43445126 |
| 152 | microtubule depolymerization (GO:0007019) | 2.42449484 |
| 153 | nucleosome organization (GO:0034728) | 2.40856763 |
| 154 | antimicrobial humoral response (GO:0019730) | 2.40128113 |
| 155 | hemopoiesis (GO:0030097) | 2.33477839 |
| 156 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.32756636 |
| 157 | meiotic chromosome segregation (GO:0045132) | 2.32386271 |
| 158 | regulation of histone H3-K9 methylation (GO:0051570) | 2.31609512 |
| 159 | angiogenesis involved in wound healing (GO:0060055) | 2.30621536 |
| 160 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.29399593 |
| 161 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.29144528 |
| 162 | ovulation from ovarian follicle (GO:0001542) | 2.28835907 |
| 163 | cysteine metabolic process (GO:0006534) | 2.27414674 |
| 164 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.26284744 |
| 165 | mitotic sister chromatid cohesion (GO:0007064) | 2.20237294 |
| 166 | chromatin assembly or disassembly (GO:0006333) | 2.19139553 |
| 167 | DNA replication initiation (GO:0006270) | 2.15191570 |
| 168 | protein autoprocessing (GO:0016540) | 2.14619131 |
| 169 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.14237601 |
| 170 | DNA replication checkpoint (GO:0000076) | 2.14162516 |
| 171 | histone H3-K36 demethylation (GO:0070544) | 2.12611568 |
| 172 | RNA stabilization (GO:0043489) | 2.11551373 |
| 173 | mRNA stabilization (GO:0048255) | 2.11551373 |
| 174 | chromosome condensation (GO:0030261) | 2.10972468 |
| 175 | positive regulation of histone deacetylation (GO:0031065) | 2.10636271 |
| 176 | lipopolysaccharide metabolic process (GO:0008653) | 2.10509546 |
| 177 | purine-containing compound salvage (GO:0043101) | 2.10093405 |
| 178 | defense response to Gram-positive bacterium (GO:0050830) | 2.09213114 |
| 179 | negative regulation of actin filament polymerization (GO:0030837) | 2.08922100 |
| 180 | hyaluronan metabolic process (GO:0030212) | 2.08758172 |
| 181 | response to folic acid (GO:0051593) | 2.08659106 |
| 182 | regulation of stem cell maintenance (GO:2000036) | 2.07475781 |
| 183 | protoporphyrinogen IX metabolic process (GO:0046501) | 18.6774203 |
| 184 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 17.3821570 |
| 185 | porphyrin-containing compound biosynthetic process (GO:0006779) | 11.9374833 |
| 186 | heme biosynthetic process (GO:0006783) | 11.2947709 |
| 187 | tetrapyrrole biosynthetic process (GO:0033014) | 10.6355266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.07385416 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.48270454 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 5.15421286 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.52156307 |
| 5 | * GATA1_19941826_ChIP-Seq_K562_Human | 4.00042841 |
| 6 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.75528350 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.44172159 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.41194580 |
| 9 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 3.39742405 |
| 10 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 3.29425912 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.05236567 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.84158356 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76604634 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.61634848 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.52509053 |
| 16 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.45875360 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44242378 |
| 18 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.43437701 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.42302972 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.36162139 |
| 21 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18203787 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.08648383 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.08482032 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98424067 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98423845 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.91982011 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.86749725 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.83927793 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75481333 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72563799 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71707044 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68503899 |
| 33 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.67019031 |
| 34 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.65321528 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.60425879 |
| 36 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.56027914 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54499141 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52521838 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51641572 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.51598651 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50718237 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48992711 |
| 43 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48378548 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47030878 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46315894 |
| 46 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45561314 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43608965 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43116578 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42747360 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42660832 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41766998 |
| 52 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.40454029 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39750570 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37940641 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37465793 |
| 56 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36053014 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35722802 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35230433 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33954947 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33898019 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31249153 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29353877 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28351212 |
| 64 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27614556 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26603257 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24108495 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22147345 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22126942 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22090741 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.21081427 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20001408 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18944936 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18803185 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18358223 |
| 75 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17192458 |
| 76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16071558 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15183404 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14474657 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14029200 |
| 80 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.13552713 |
| 81 | MYB_26560356_Chip-Seq_TH1_Human | 1.13354237 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12906995 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12059451 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11569017 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11086653 |
| 86 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08036862 |
| 87 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07932017 |
| 88 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07703261 |
| 89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.06139310 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05464567 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02361588 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01903131 |
| 93 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00525338 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00036034 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00028680 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99459983 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98969552 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96023354 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95450645 |
| 100 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95382849 |
| 101 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.94751571 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93456568 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92222875 |
| 104 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.90817787 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90049603 |
| 106 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90008943 |
| 107 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.89695798 |
| 108 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89616083 |
| 109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89044150 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 0.88761316 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87733150 |
| 112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87090893 |
| 113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86773573 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85969720 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85367376 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85279820 |
| 117 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85014494 |
| 118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84861592 |
| 119 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.84410015 |
| 120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83278800 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81775904 |
| 122 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79777497 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79755836 |
| 124 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78996121 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78915470 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78886755 |
| 127 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78737685 |
| 128 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.78406697 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77148920 |
| 130 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76357911 |
| 131 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.76065321 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75607875 |
| 133 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.74038870 |
| 134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.72792835 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71261031 |
| 136 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71227783 |
| 137 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71169907 |
| 138 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.70822032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 9.13350037 |
| 2 | MP0003724_increased_susceptibility_to | 4.38381289 |
| 3 | MP0005083_abnormal_biliary_tract | 3.30601306 |
| 4 | MP0003111_abnormal_nucleus_morphology | 2.69405155 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.53390351 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 2.53390351 |
| 7 | MP0005451_abnormal_body_composition | 2.50357457 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.46452737 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.21499929 |
| 10 | MP0000685_abnormal_immune_system | 2.08633866 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.02170291 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.01820518 |
| 13 | MP0004381_abnormal_hair_follicle | 2.00151379 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 10.3695581 |
| 15 | MP0002396_abnormal_hematopoietic_system | 1.93666000 |
| 16 | MP0010094_abnormal_chromosome_stability | 1.91842749 |
| 17 | MP0002139_abnormal_hepatobiliary_system | 1.78108541 |
| 18 | MP0002398_abnormal_bone_marrow | 1.77825540 |
| 19 | MP0010307_abnormal_tumor_latency | 1.76729332 |
| 20 | MP0003077_abnormal_cell_cycle | 1.75050744 |
| 21 | MP0003303_peritoneal_inflammation | 1.73111621 |
| 22 | MP0004883_abnormal_blood_vessel | 1.70416967 |
| 23 | MP0006082_CNS_inflammation | 1.67038110 |
| 24 | MP0005636_abnormal_mineral_homeostasis | 1.66893560 |
| 25 | MP0009278_abnormal_bone_marrow | 1.61368581 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 1.57462986 |
| 27 | MP0003828_pulmonary_edema | 1.57455050 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.56315568 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.54698190 |
| 30 | MP0002722_abnormal_immune_system | 1.50013534 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.49366833 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.48471628 |
| 33 | MP0005310_abnormal_salivary_gland | 1.44660323 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.43702863 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.43549642 |
| 36 | MP0003866_abnormal_defecation | 1.39305065 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.39203891 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37062360 |
| 39 | MP0005360_urolithiasis | 1.36927469 |
| 40 | MP0008057_abnormal_DNA_replication | 1.35264811 |
| 41 | MP0002429_abnormal_blood_cell | 1.34842894 |
| 42 | MP0005164_abnormal_response_to | 1.28014856 |
| 43 | MP0005387_immune_system_phenotype | 1.24778845 |
| 44 | MP0001790_abnormal_immune_system | 1.24778845 |
| 45 | MP0000490_abnormal_crypts_of | 1.24084030 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.22471829 |
| 47 | MP0003787_abnormal_imprinting | 1.21391241 |
| 48 | MP0005671_abnormal_response_to | 1.20858942 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.19795051 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.17893333 |
| 51 | MP0005085_abnormal_gallbladder_physiolo | 1.17886643 |
| 52 | MP0009931_abnormal_skin_appearance | 1.14012300 |
| 53 | MP0001800_abnormal_humoral_immune | 1.13383332 |
| 54 | MP0004130_abnormal_muscle_cell | 1.13363982 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.11559787 |
| 56 | MP0005025_abnormal_response_to | 1.11106195 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.10166218 |
| 58 | MP0000609_abnormal_liver_physiology | 1.09818402 |
| 59 | MP0009764_decreased_sensitivity_to | 1.09708647 |
| 60 | MP0003436_decreased_susceptibility_to | 1.09674746 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.09536914 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.08329350 |
| 63 | MP0002405_respiratory_system_inflammati | 1.08247330 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.06880142 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.06668797 |
| 66 | MP0000350_abnormal_cell_proliferation | 1.04313431 |
| 67 | MP0004947_skin_inflammation | 1.03186000 |
| 68 | MP0001851_eye_inflammation | 1.03177903 |
| 69 | MP0000716_abnormal_immune_system | 1.01904114 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.01323828 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.00366956 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.00183435 |
| 73 | MP0002452_abnormal_antigen_presenting | 0.99817955 |
| 74 | MP0005501_abnormal_skin_physiology | 0.99106814 |
| 75 | MP0008995_early_reproductive_senescence | 0.97222213 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 0.96252432 |
| 77 | MP0002419_abnormal_innate_immunity | 0.95317475 |
| 78 | MP0005000_abnormal_immune_tolerance | 0.94221847 |
| 79 | MP0002420_abnormal_adaptive_immunity | 0.93894638 |
| 80 | MP0001819_abnormal_immune_cell | 0.92703126 |
| 81 | MP0009053_abnormal_anal_canal | 0.92010253 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.88686308 |
| 83 | MP0008770_decreased_survivor_rate | 0.88111353 |
| 84 | MP0003186_abnormal_redox_activity | 0.88068827 |
| 85 | MP0009763_increased_sensitivity_to | 0.88032144 |
| 86 | MP0000598_abnormal_liver_morphology | 0.87994052 |
| 87 | MP0000313_abnormal_cell_death | 0.87879914 |
| 88 | MP0003045_fibrosis | 0.85265174 |
| 89 | MP0006054_spinal_hemorrhage | 0.84625503 |
| 90 | MP0004484_altered_response_of | 0.83883239 |
| 91 | MP0003690_abnormal_glial_cell | 0.83804920 |
| 92 | MP0000858_altered_metastatic_potential | 0.83422775 |
| 93 | MP0002723_abnormal_immune_serum | 0.81220476 |
| 94 | MP0009785_altered_susceptibility_to | 0.80803711 |
| 95 | MP0003646_muscle_fatigue | 0.80433555 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.79388095 |
| 97 | MP0010329_abnormal_lipoprotein_level | 0.78029499 |
| 98 | MP0001663_abnormal_digestive_system | 0.77768600 |
| 99 | MP0002086_abnormal_extraembryonic_tissu | 0.77155076 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.76793659 |
| 101 | MP0002006_tumorigenesis | 0.76416373 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.76389269 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.75355317 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.74045788 |
| 105 | MP0010155_abnormal_intestine_physiology | 0.71314899 |
| 106 | MP0008872_abnormal_physiological_respon | 0.70012897 |
| 107 | MP0008469_abnormal_protein_level | 0.69445541 |
| 108 | MP0005621_abnormal_cell_physiology | 0.69345406 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.69201924 |
| 110 | MP0005023_abnormal_wound_healing | 0.66920696 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.66852328 |
| 112 | MP0004264_abnormal_extraembryonic_tissu | 0.66512526 |
| 113 | MP0008874_decreased_physiological_sensi | 0.65373601 |
| 114 | MP0003252_abnormal_bile_duct | 0.65357677 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.65026825 |
| 116 | MP0008260_abnormal_autophagy | 0.63351751 |
| 117 | MP0002132_abnormal_respiratory_system | 0.62894160 |
| 118 | MP0009840_abnormal_foam_cell | 0.62727415 |
| 119 | MP0004510_myositis | 0.62315639 |
| 120 | MP0002095_abnormal_skin_pigmentation | 0.62074093 |
| 121 | MP0002928_abnormal_bile_duct | 0.61699487 |
| 122 | MP0001853_heart_inflammation | 0.61413992 |
| 123 | MP0000343_altered_response_to | 0.61319061 |
| 124 | MP0005365_abnormal_bile_salt | 0.61108323 |
| 125 | MP0002080_prenatal_lethality | 0.60569345 |
| 126 | MP0001730_embryonic_growth_arrest | 0.60469343 |
| 127 | MP0001191_abnormal_skin_condition | 0.60386301 |
| 128 | MP0000371_diluted_coat_color | 0.59441064 |
| 129 | MP0004197_abnormal_fetal_growth/weight/ | 0.59420724 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.59172481 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.58972620 |
| 132 | MP0003984_embryonic_growth_retardation | 0.58531608 |
| 133 | MP0009643_abnormal_urine_homeostasis | 0.58022505 |
| 134 | MP0005377_hearing/vestibular/ear_phenot | 0.57219391 |
| 135 | MP0003878_abnormal_ear_physiology | 0.57219391 |
| 136 | MP0002088_abnormal_embryonic_growth/wei | 0.56524407 |
| 137 | MP0008877_abnormal_DNA_methylation | 0.56518214 |
| 138 | MP0001666_abnormal_nutrient_absorption | 0.55601901 |
| 139 | MP0001243_abnormal_dermal_layer | 0.55562086 |
| 140 | MP0005384_cellular_phenotype | 0.54414328 |
| 141 | MP0000604_amyloidosis | 0.53966456 |
| 142 | MP0000249_abnormal_blood_vessel | 0.49596346 |
| 143 | MP0003448_altered_tumor_morphology | 0.47649566 |
| 144 | MP0005266_abnormal_metabolism | 0.47358574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 9.93763563 |
| 2 | Acanthocytosis (HP:0001927) | 8.94901619 |
| 3 | Reticulocytosis (HP:0001923) | 8.13939917 |
| 4 | Cholelithiasis (HP:0001081) | 6.61968800 |
| 5 | Abnormal gallbladder morphology (HP:0012437) | 5.96413171 |
| 6 | Paralysis (HP:0003470) | 5.51120175 |
| 7 | Diaphragmatic weakness (HP:0009113) | 5.46068962 |
| 8 | Abnormality of reticulocytes (HP:0004312) | 5.39693641 |
| 9 | Hypochromic anemia (HP:0001931) | 5.26395222 |
| 10 | Hyperbilirubinemia (HP:0002904) | 5.19174842 |
| 11 | Myositis (HP:0100614) | 5.00011107 |
| 12 | Osteomalacia (HP:0002749) | 4.84216437 |
| 13 | Orchitis (HP:0100796) | 4.82960108 |
| 14 | Optic neuritis (HP:0100653) | 4.71063306 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 4.71063306 |
| 16 | Insomnia (HP:0100785) | 4.45755780 |
| 17 | Microcytic anemia (HP:0001935) | 4.31436245 |
| 18 | Abnormality of the gallbladder (HP:0005264) | 4.16331755 |
| 19 | Stomatitis (HP:0010280) | 3.93918022 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93855370 |
| 21 | Cutaneous photosensitivity (HP:0000992) | 3.92784920 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.91626363 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.80711943 |
| 24 | Abnormal gallbladder physiology (HP:0012438) | 3.76706133 |
| 25 | Cholecystitis (HP:0001082) | 3.76706133 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.74636074 |
| 27 | Recurrent skin infections (HP:0001581) | 3.66331634 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.56907156 |
| 29 | Obstructive lung disease (HP:0006536) | 3.51938770 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.51938770 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.49019263 |
| 32 | Gingivitis (HP:0000230) | 3.48543573 |
| 33 | Polycythemia (HP:0001901) | 3.47414401 |
| 34 | Encephalitis (HP:0002383) | 3.34794911 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.29137716 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.29137716 |
| 37 | Hepatocellular carcinoma (HP:0001402) | 3.24397688 |
| 38 | Meningitis (HP:0001287) | 3.24054229 |
| 39 | Ileus (HP:0002595) | 3.23480831 |
| 40 | Peritonitis (HP:0002586) | 3.23390533 |
| 41 | Abnormal hemoglobin (HP:0011902) | 3.17587700 |
| 42 | Leukocytosis (HP:0001974) | 3.09559019 |
| 43 | Slow saccadic eye movements (HP:0000514) | 3.05859987 |
| 44 | Pustule (HP:0200039) | 3.03866471 |
| 45 | Vasculitis (HP:0002633) | 3.01180962 |
| 46 | Urticaria (HP:0001025) | 2.95517825 |
| 47 | Arterial thrombosis (HP:0004420) | 2.93914547 |
| 48 | Chest pain (HP:0100749) | 2.92832565 |
| 49 | Abnormality of T cells (HP:0002843) | 2.85454173 |
| 50 | Anorexia (HP:0002039) | 2.75850866 |
| 51 | Abnormality of the fingertips (HP:0001211) | 2.61867729 |
| 52 | Increased serum ferritin (HP:0003281) | 2.59661184 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.58410070 |
| 54 | Granulocytopenia (HP:0001913) | 2.58009993 |
| 55 | Hemoptysis (HP:0002105) | 2.57714081 |
| 56 | Petechiae (HP:0000967) | 2.56661769 |
| 57 | Toxemia of pregnancy (HP:0100603) | 2.56441437 |
| 58 | Abnormality of iron homeostasis (HP:0011031) | 2.54384790 |
| 59 | Subacute progressive viral hepatitis (HP:0006572) | 2.49298480 |
| 60 | Episodic fever (HP:0001954) | 2.48892220 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.48422877 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.47403057 |
| 63 | Pathologic fracture (HP:0002756) | 2.46419664 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.44754675 |
| 65 | Renal tubular acidosis (HP:0001947) | 2.38666241 |
| 66 | Eosinophilia (HP:0001880) | 2.38609487 |
| 67 | Increased IgE level (HP:0003212) | 2.38426163 |
| 68 | Abnormal number of erythroid precursors (HP:0012131) | 2.37362499 |
| 69 | Postural instability (HP:0002172) | 2.36785641 |
| 70 | Gastrointestinal inflammation (HP:0004386) | 2.34244463 |
| 71 | Hyponatremia (HP:0002902) | 2.32323791 |
| 72 | Visual hallucinations (HP:0002367) | 2.31458041 |
| 73 | Viral hepatitis (HP:0006562) | 2.26511414 |
| 74 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.25214098 |
| 75 | Nausea (HP:0002018) | 2.24116937 |
| 76 | Panhypogammaglobulinemia (HP:0003139) | 2.22959598 |
| 77 | Epistaxis (HP:0000421) | 2.20665010 |
| 78 | Pulmonary embolism (HP:0002204) | 2.20017556 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 2.18633883 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.15589479 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.15239257 |
| 82 | Abnormality of sodium homeostasis (HP:0010931) | 2.11429527 |
| 83 | Nonimmune hydrops fetalis (HP:0001790) | 2.10054042 |
| 84 | Abnormal platelet volume (HP:0011876) | 2.08586616 |
| 85 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.06267925 |
| 86 | Generalized hyperpigmentation (HP:0007440) | 2.05945010 |
| 87 | Increased mean platelet volume (HP:0011877) | 2.04937632 |
| 88 | Acute hepatic failure (HP:0006554) | 2.03599538 |
| 89 | Keratitis (HP:0000491) | 2.02301101 |
| 90 | Global brain atrophy (HP:0002283) | 2.01231218 |
| 91 | Poikilocytosis (HP:0004447) | 12.7230263 |
| 92 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 12.0987577 |
| 93 | Papilloma (HP:0012740) | 1.98400030 |
| 94 | Verrucae (HP:0200043) | 1.98400030 |
| 95 | Impaired platelet aggregation (HP:0003540) | 1.97437490 |
| 96 | Abnormal platelet function (HP:0011869) | 1.97437490 |
| 97 | Abnormality of eosinophils (HP:0001879) | 1.94880312 |
| 98 | Increased IgM level (HP:0003496) | 1.92725224 |
| 99 | Recurrent abscess formation (HP:0002722) | 1.92668355 |
| 100 | Recurrent bronchitis (HP:0002837) | 1.91795626 |
| 101 | Abnormality of the pleura (HP:0002103) | 1.91750511 |
| 102 | Gangrene (HP:0100758) | 1.89819402 |
| 103 | Confusion (HP:0001289) | 1.89372457 |
| 104 | Glomerulopathy (HP:0100820) | 1.89081526 |
| 105 | Lymphopenia (HP:0001888) | 1.87554329 |
| 106 | Recurrent viral infections (HP:0004429) | 1.87537858 |
| 107 | Sepsis (HP:0100806) | 1.85546846 |
| 108 | Acne (HP:0001061) | 1.82630562 |
| 109 | Onycholysis (HP:0001806) | 1.81472863 |
| 110 | Vertigo (HP:0002321) | 1.81362292 |
| 111 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80751184 |
| 112 | Hematochezia (HP:0002573) | 1.79949381 |
| 113 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.79131304 |
| 114 | Cerebral palsy (HP:0100021) | 1.77676625 |
| 115 | Lower limb hyperreflexia (HP:0002395) | 1.77294200 |
| 116 | Short middle phalanx of the 5th finger (HP:0004220) | 1.76837485 |
| 117 | Cellulitis (HP:0100658) | 1.74466719 |
| 118 | Purpura (HP:0000979) | 1.73128160 |
| 119 | Deep venous thrombosis (HP:0002625) | 1.70973847 |
| 120 | High pitched voice (HP:0001620) | 1.69268790 |
| 121 | Basal cell carcinoma (HP:0002671) | 1.67381191 |
| 122 | Gingival bleeding (HP:0000225) | 1.65753953 |
| 123 | Birth length less than 3rd percentile (HP:0003561) | 1.64829697 |
| 124 | Joint hemorrhage (HP:0005261) | 1.64492563 |
| 125 | Recurrent bacterial skin infections (HP:0005406) | 1.63019946 |
| 126 | Eczematoid dermatitis (HP:0000976) | 1.63002453 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.62203402 |
| 128 | Rickets (HP:0002748) | 1.56690267 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.56367468 |
| 130 | Hypertensive crisis (HP:0100735) | 1.53706164 |
| 131 | Menorrhagia (HP:0000132) | 1.51532522 |
| 132 | Hypertriglyceridemia (HP:0002155) | 1.50570597 |
| 133 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.47907145 |
| 134 | Neoplasm of the liver (HP:0002896) | 1.46128964 |
| 135 | Childhood onset (HP:0011463) | 1.45278308 |
| 136 | Thrombophlebitis (HP:0004418) | 1.41977666 |
| 137 | T lymphocytopenia (HP:0005403) | 1.41634110 |
| 138 | Broad palm (HP:0001169) | 1.39873431 |
| 139 | Cafe-au-lait spot (HP:0000957) | 1.39299005 |
| 140 | Recurrent sinusitis (HP:0011108) | 1.36117394 |
| 141 | Gastrointestinal infarctions (HP:0005244) | 1.35665427 |
| 142 | Splenomegaly (HP:0001744) | 1.34535319 |
| 143 | Recurrent fungal infections (HP:0002841) | 1.33866519 |
| 144 | Abnormal blistering of the skin (HP:0008066) | 1.32355356 |
| 145 | Macrocytic anemia (HP:0001972) | 1.31868845 |
| 146 | Prostate neoplasm (HP:0100787) | 1.31643797 |
| 147 | Abnormality of T cell number (HP:0011839) | 1.30747425 |
| 148 | Abnormality of the common coagulation pathway (HP:0010990) | 1.29374796 |
| 149 | Colitis (HP:0002583) | 1.28639882 |
| 150 | Mediastinal lymphadenopathy (HP:0100721) | 1.27613054 |
| 151 | Short 5th finger (HP:0009237) | 1.27601952 |
| 152 | Prominent nose (HP:0000448) | 1.27320508 |
| 153 | Osteomyelitis (HP:0002754) | 1.27186397 |
| 154 | Long eyelashes (HP:0000527) | 1.25234253 |
| 155 | Combined immunodeficiency (HP:0005387) | 1.24748420 |
| 156 | Long clavicles (HP:0000890) | 1.24726795 |
| 157 | IgM deficiency (HP:0002850) | 1.23989876 |
| 158 | Thin skin (HP:0000963) | 1.23770139 |
| 159 | Heterotopia (HP:0002282) | 1.22254100 |
| 160 | Poikiloderma (HP:0001029) | 1.20831272 |
| 161 | Entropion (HP:0000621) | 1.20680796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 5.60363693 |
| 2 | RIPK4 | 4.67424708 |
| 3 | CDK12 | 3.35601426 |
| 4 | STK4 | 3.33844170 |
| 5 | CDC7 | 2.90776191 |
| 6 | TLK1 | 2.89049909 |
| 7 | EEF2K | 2.50177605 |
| 8 | STK10 | 2.48011333 |
| 9 | FGR | 2.32236481 |
| 10 | MAP3K10 | 2.11424493 |
| 11 | BRSK1 | 2.06541626 |
| 12 | MAP4K1 | 2.05325864 |
| 13 | FES | 2.04020467 |
| 14 | NEK2 | 1.93777860 |
| 15 | ZAK | 1.84046619 |
| 16 | PRPF4B | 1.83588144 |
| 17 | PIM1 | 1.82721084 |
| 18 | PTK2B | 1.77630124 |
| 19 | GRK6 | 1.76553038 |
| 20 | TRPM7 | 1.75378636 |
| 21 | PKN2 | 1.71052992 |
| 22 | CDK6 | 1.57469633 |
| 23 | MAPK11 | 1.56932679 |
| 24 | TXK | 1.56894539 |
| 25 | TNK2 | 1.55072036 |
| 26 | SYK | 1.54537616 |
| 27 | EPHB1 | 1.50626234 |
| 28 | WNK1 | 1.49203026 |
| 29 | TRIB3 | 1.48865711 |
| 30 | MAP3K8 | 1.43776125 |
| 31 | MAP2K3 | 1.40499495 |
| 32 | CDK4 | 1.39403594 |
| 33 | KSR2 | 1.38133191 |
| 34 | MAP3K1 | 1.38098593 |
| 35 | BRD4 | 1.36043192 |
| 36 | TYK2 | 1.32473393 |
| 37 | ERN1 | 1.32334682 |
| 38 | SGK2 | 1.31010586 |
| 39 | TGFBR2 | 1.28340761 |
| 40 | MAP3K2 | 1.24818923 |
| 41 | STK3 | 1.23528778 |
| 42 | TAOK3 | 1.23207197 |
| 43 | NME2 | 1.22521351 |
| 44 | MAP3K13 | 1.22230685 |
| 45 | YES1 | 1.15171861 |
| 46 | IKBKE | 1.13803947 |
| 47 | RPS6KA5 | 1.13801682 |
| 48 | TAOK1 | 1.13322254 |
| 49 | BMPR2 | 1.12359034 |
| 50 | CAMK1D | 1.12290977 |
| 51 | GRK5 | 1.12109204 |
| 52 | AURKB | 1.10458575 |
| 53 | MARK2 | 1.09624115 |
| 54 | MAPKAPK3 | 1.04944533 |
| 55 | VRK1 | 1.04731456 |
| 56 | MELK | 1.03657286 |
| 57 | TEC | 1.03504361 |
| 58 | IRAK1 | 1.03091948 |
| 59 | PIK3CG | 1.01544317 |
| 60 | DYRK3 | 1.00644604 |
| 61 | JAK3 | 1.00438325 |
| 62 | CDK9 | 0.97667823 |
| 63 | MAP3K11 | 0.96115242 |
| 64 | MAP3K6 | 0.95690274 |
| 65 | KSR1 | 0.94204024 |
| 66 | FGFR3 | 0.94110776 |
| 67 | JAK2 | 0.93735746 |
| 68 | FLT3 | 0.93331911 |
| 69 | ITK | 0.92622419 |
| 70 | BRSK2 | 0.92551667 |
| 71 | LRRK2 | 0.88107180 |
| 72 | BMX | 0.87621082 |
| 73 | CLK1 | 0.86366097 |
| 74 | TBK1 | 0.86280932 |
| 75 | ERBB2 | 0.85844988 |
| 76 | FRK | 0.84306883 |
| 77 | MATK | 0.83297854 |
| 78 | LYN | 0.82364278 |
| 79 | SCYL2 | 0.81943640 |
| 80 | STK11 | 0.81639971 |
| 81 | RPS6KB2 | 0.80130943 |
| 82 | TTK | 0.77787801 |
| 83 | MAP3K7 | 0.77385800 |
| 84 | ATR | 0.77344684 |
| 85 | SIK2 | 0.77168824 |
| 86 | RAF1 | 0.76707711 |
| 87 | CHEK2 | 0.76302358 |
| 88 | IKBKB | 0.75222125 |
| 89 | IRAK2 | 0.73602894 |
| 90 | CHEK1 | 0.73418943 |
| 91 | SGK3 | 0.72994518 |
| 92 | MAP3K5 | 0.72816363 |
| 93 | HIPK2 | 0.71774268 |
| 94 | SGK494 | 0.71554915 |
| 95 | SGK223 | 0.71554915 |
| 96 | STK38 | 0.71378485 |
| 97 | CDC42BPA | 0.70752704 |
| 98 | MAP2K4 | 0.70126130 |
| 99 | ATM | 0.70096695 |
| 100 | PLK2 | 0.64675237 |
| 101 | KIT | 0.64421069 |
| 102 | PDK1 | 0.64059375 |
| 103 | ZAP70 | 0.63516024 |
| 104 | MAP3K14 | 0.63412604 |
| 105 | PRKAA1 | 0.63098301 |
| 106 | RPS6KA4 | 0.62561243 |
| 107 | NLK | 0.62090920 |
| 108 | CAMK1G | 0.61375729 |
| 109 | IRAK4 | 0.60897121 |
| 110 | IRAK3 | 0.60281271 |
| 111 | MAPKAPK2 | 0.59526146 |
| 112 | AURKA | 0.59024107 |
| 113 | JAK1 | 0.57750622 |
| 114 | SGK1 | 0.57445071 |
| 115 | TTN | 0.56475039 |
| 116 | CHUK | 0.55441505 |
| 117 | MARK3 | 0.55295796 |
| 118 | PRKD2 | 0.54221763 |
| 119 | SIK1 | 0.53559443 |
| 120 | DYRK1A | 0.53326092 |
| 121 | PRKAA2 | 0.53309071 |
| 122 | DYRK1B | 0.52309829 |
| 123 | BUB1 | 0.51819001 |
| 124 | PBK | 0.50799936 |
| 125 | NEK9 | 0.50535740 |
| 126 | PDPK1 | 0.49127290 |
| 127 | BLK | 0.48949740 |
| 128 | BTK | 0.48732338 |
| 129 | LCK | 0.48712654 |
| 130 | PLK1 | 0.48630192 |
| 131 | CSF1R | 0.48135664 |
| 132 | FYN | 0.48014933 |
| 133 | MAPK12 | 0.45571226 |
| 134 | MTOR | 0.45139699 |
| 135 | ABL2 | 0.44594149 |
| 136 | CSK | 0.44578452 |
| 137 | CSNK1D | 0.44305375 |
| 138 | PRKCQ | 0.44006290 |
| 139 | CDK2 | 0.43782464 |
| 140 | RPS6KC1 | 0.42168000 |
| 141 | RPS6KL1 | 0.42168000 |
| 142 | PTK6 | 0.41739038 |
| 143 | HCK | 0.41215450 |
| 144 | NEK1 | 0.41191243 |
| 145 | RET | 0.40877034 |
| 146 | RPS6KA6 | 0.40828719 |
| 147 | STK24 | 0.40362124 |
| 148 | MAP3K3 | 0.39720004 |
| 149 | TAOK2 | 0.39652097 |
| 150 | SIK3 | 0.35103561 |
| 151 | ADRBK1 | 0.34035425 |
| 152 | CAMKK2 | 0.33514322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 8.08945513 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 5.00714733 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.21452496 |
| 4 | Alcoholism_Homo sapiens_hsa05034 | 2.32145552 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.17917965 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.15996987 |
| 7 | Cell cycle_Homo sapiens_hsa04110 | 2.09133730 |
| 8 | ABC transporters_Homo sapiens_hsa02010 | 1.94918574 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.90436693 |
| 10 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.67376583 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.60467490 |
| 12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52184841 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51964163 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.46827461 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.38241931 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37303193 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.36713127 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36435581 |
| 19 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35677542 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35069746 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.32717436 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29848596 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29461854 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28881751 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21875619 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21198961 |
| 27 | Bladder cancer_Homo sapiens_hsa05219 | 1.20811402 |
| 28 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.19855283 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.19852939 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16054824 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.15711769 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12181232 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.11618456 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11550486 |
| 35 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10965727 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10446848 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10210614 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09407408 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08452469 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07303150 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.04470736 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00573473 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99941307 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 0.99453910 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99339804 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98335551 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94284098 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 0.93663930 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.93427712 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92627782 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90189179 |
| 52 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89147214 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88687982 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88408647 |
| 55 | Base excision repair_Homo sapiens_hsa03410 | 0.88182159 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87690445 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87604511 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83297235 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82565998 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79060902 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78799641 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78154129 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77941529 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77705651 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77056338 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76068341 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.75584480 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74335806 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71790976 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69902102 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69647013 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68261310 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.67505009 |
| 74 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66287647 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66261475 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65341541 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65239772 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.65214657 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65189846 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65185415 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.64666709 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64337367 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64222814 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63922886 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62826980 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62785776 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.62629486 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.62401438 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62350625 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62152933 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61280984 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59915841 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58173000 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57304375 |
| 95 | Homologous recombination_Homo sapiens_hsa03440 | 0.57225449 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.56457025 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55806638 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54295580 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54025379 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.53015035 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.52465433 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52064767 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.51920012 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51727694 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51187576 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50370553 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48923814 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48841435 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47931231 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47104790 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45040640 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44199605 |
| 113 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43638902 |
| 114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43210096 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.43153339 |
| 116 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42833658 |
| 117 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42493680 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42259114 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.40852267 |
| 120 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40339927 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40071607 |
| 122 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39619768 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38552524 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37811373 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36388576 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36192170 |
| 127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35928694 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.35139237 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34909919 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33894169 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32141371 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31695206 |
| 133 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31331375 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.29855640 |
| 135 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28187568 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27168530 |
| 137 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26991837 |
| 138 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.26633025 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23823337 |
| 140 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.22907745 |
| 141 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22792855 |
| 142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22356487 |
| 143 | Melanoma_Homo sapiens_hsa05218 | 0.22348394 |
| 144 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.22338893 |

